{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,21]],"date-time":"2026-02-21T11:39:08Z","timestamp":1771673948906,"version":"3.50.1"},"reference-count":37,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2016,8,11]],"date-time":"2016-08-11T00:00:00Z","timestamp":1470873600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2016,8,11]],"date-time":"2016-08-11T00:00:00Z","timestamp":1470873600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Hum Hypertens"],"published-print":{"date-parts":[[2017,2]]},"DOI":"10.1038\/jhh.2016.46","type":"journal-article","created":{"date-parts":[[2016,8,11]],"date-time":"2016-08-11T09:23:29Z","timestamp":1470907409000},"page":"79-88","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["High-dose calcium channel blocker (CCB) monotherapy vs combination therapy of standard-dose CCBs and angiotensin receptor blockers for hypertension: a meta-analysis"],"prefix":"10.1038","volume":"31","author":[{"given":"T","family":"He","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"X","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Y","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"X Y","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Q Y","family":"Wu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M L","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"H","family":"Yuan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2016,8,11]]},"reference":[{"key":"BFjhh201646_CR1","doi-asserted-by":"publisher","first-page":"539","DOI":"10.1016\/S0140-6736(12)61219-7","volume":"380","author":"EL Schiffrin","year":"2012","unstructured":"Schiffrin EL . Hypertension: treatments, diabetes, and developing regions. Lancet 2012; 380: 539\u2013541.","journal-title":"Lancet"},{"key":"BFjhh201646_CR2","doi-asserted-by":"publisher","first-page":"611","DOI":"10.1016\/S0140-6736(12)60861-7","volume":"380","author":"MM Ibrahim","year":"2012","unstructured":"Ibrahim MM, Damasceno A . Hypertension in developing countries. Lancet 2012; 380: 611\u2013619.","journal-title":"Lancet"},{"key":"BFjhh201646_CR3","first-page":"230","volume":"38","author":"DY Hu","year":"2010","unstructured":"Hu DY, Liu LS, Yu JM, Yao CH . National survey of blood pressure control rate in Chinese hypertensive outpatients-China STATUS. Zhonghua Xin Xue Guan Bing Za Zhi 2010; 38: 230\u2013238.","journal-title":"Zhonghua Xin Xue Guan Bing Za Zhi"},{"key":"BFjhh201646_CR4","doi-asserted-by":"publisher","first-page":"366","DOI":"10.1016\/S0140-6736(00)02527-7","volume":"356","author":"MJ Brown","year":"2000","unstructured":"Brown MJ, Palmer CR, Castaigne A, de Leeuw PW, Mancia G, Rosenthal T et al. Morbidity and mortality in patients randomised to double-blind treatment with a long-acting calcium-channel blocker or diuretic in the International Nifedipine GITS study: intervention as a Goal in Hypertension Treatment (INSIGHT). Lancet 2000; 356: 366\u2013372.","journal-title":"Lancet"},{"key":"BFjhh201646_CR5","doi-asserted-by":"publisher","first-page":"1129","DOI":"10.1161\/01.HYP.34.5.1129","volume":"34","author":"National Intervention Cooperative Study in Elderly Hypertensives Study Group","year":"1999","unstructured":"National Intervention Cooperative Study in Elderly Hypertensives Study Group. Randomized double-blind comparison of a calcium antagonist and a diuretic in elderly hypertensives. Hypertension 1999; 34: 1129\u20131133.","journal-title":"Hypertension"},{"key":"BFjhh201646_CR6","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1177\/1074248414555403","volume":"20","author":"G Tocci","year":"2015","unstructured":"Tocci G, Battistoni A, Passerini J, Musumeci MB, Francia P, Ferrucci A et al. Calcium channel blockers and hypertension. J Cardiovasc Pharmacol Ther 2015; 20: 121\u2013130.","journal-title":"J Cardiovasc Pharmacol Ther"},{"key":"BFjhh201646_CR7","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1177\/0300060513503756","volume":"42","author":"DL Zhu","year":"2014","unstructured":"Zhu DL, Gao PJ, Holtbruegge W, Huang CL . A randomized, double-blind study to evaluate the efficacy and safety of a single-pill combination of telmisartan 80\u2009mg\/amlodipine 5\u2009mg versus amlodipine 5\u2009mg in hypertensive Asian patients. J Int Med Res 2014; 42: 52\u201366.","journal-title":"J Int Med Res"},{"key":"BFjhh201646_CR8","doi-asserted-by":"publisher","first-page":"1132","DOI":"10.1161\/HYPERTENSIONAHA.111.189217","volume":"59","author":"Y Matsui","year":"2012","unstructured":"Matsui Y, O'Rourke MF, Hoshide S, Ishikawa J, Shimada K, Kario K . Combined effect of angiotensin II receptor blocker and either a calcium channel blocker or diuretic on day-by-day variability of home blood pressure: the Japan Combined Treatment With Olmesartan and a Calcium-Channel Blocker Versus Olmesartan and Diuretics Randomized Efficacy Study. Hypertension 2012; 59: 1132\u20131138.","journal-title":"Hypertension"},{"key":"BFjhh201646_CR9","doi-asserted-by":"crossref","unstructured":"Lu Z, Chen Y, Li L, Wang G, Xue H, Tang W . Combination therapy of renin-angiotensin system inhibitors plus calcium channel blockers versus other two-drug combinations for hypertension: a systematic review and meta-analysis. J Hum Hypertens, (e-pub ahead of print 7 January 2016; doi:10.1038\/jhh.2015.125).","DOI":"10.1038\/jhh.2015.125"},{"key":"BFjhh201646_CR10","unstructured":"Chi C, Tai C, Bai B, Yu S, Karamanou M, Wang J et al. Angiotensin system blockade combined with calcium channel blockers is superior to other combinations in cardiovascular protection with similar blood pressure reduction: a meta-analysis in 20451 hypertensive patients. J Clin Hypertens (Greenwich), (e-pub ahead of print 17 January 2016; doi:10.1111\/jch.12771)."},{"key":"BFjhh201646_CR11","first-page":"2243","volume":"7","author":"J Ma","year":"2015","unstructured":"Ma J, Wang XY, Hu ZD, Zhou ZR, Schoenhagen P, Wang H . Meta-analysis of the efficacy and safety of adding an angiotensin receptor blocker (ARB) to a calcium channel blocker (CCB) following ineffective CCB monotherapy. J Thorac Dis 2015; 7: 2243\u20132252.","journal-title":"J Thorac Dis"},{"key":"BFjhh201646_CR12","doi-asserted-by":"publisher","first-page":"1448","DOI":"10.1046\/j.1365-2168.2000.01610.x","volume":"87","author":"D Moher","year":"2000","unstructured":"Moher D, Cook DJ, Eastwood S, Olkin I, Rennie D, Stroup DF . Improving the quality of reports of meta-analyses of randomised controlled trials: the QUOROM statement. QUOROM Group. Br J Surg 2000; 87: 1448\u20131454.","journal-title":"Br J Surg"},{"key":"BFjhh201646_CR13","doi-asserted-by":"publisher","DOI":"10.1002\/9780470712184","volume-title":"Cochrane Handbook for Systematic Reviews of Interventions: cochrane Book Series","author":"JPT Higgins","year":"2008","unstructured":"Higgins JPT, Green S (eds). Cochrane Handbook for Systematic Reviews of Interventions: cochrane Book Series. John Wiley & Sons: Chichester, UK, 2008."},{"key":"BFjhh201646_CR14","doi-asserted-by":"publisher","first-page":"924","DOI":"10.1136\/bmj.39489.470347.AD","volume":"336","author":"GH Guyatt","year":"2008","unstructured":"Guyatt GH, Oxman AD, Vist GE, Kunz R, Falck-Ytter Y, Alonso-Coello P et al. GRADE: an emerging consensus on rating quality of evidence and strength of recommendations. BMJ 2008; 336: 924\u2013926.","journal-title":"BMJ"},{"key":"BFjhh201646_CR15","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1038\/sj.jhh.1001843","volume":"19","author":"EA Andreadis","year":"2005","unstructured":"Andreadis EA, Tsourous GI, Marakomichelakis GE, Katsanou PM, Fotia ME, Vassilopoulos CV et al. High-dose monotherapy vs low-dose combination therapy of calcium channel blockers and angiotensin receptor blockers in mild to moderate hypertension. J Hum Hypertens 2005; 19: 491\u2013496.","journal-title":"J Hum Hypertens"},{"key":"BFjhh201646_CR16","first-page":"266","volume":"29","author":"EA Andreadis","year":"2010","unstructured":"Andreadis EA, Sfakianakis ME, Tsourous GI, Georgiopoulos DX, Fragouli EG, Katsanou PM et al. Differential impact of angiotensin receptor blockers and calcium channel blockers on arterial stiffness. Int Angiol 2010; 29: 266\u2013272.","journal-title":"Int Angiol"},{"key":"BFjhh201646_CR17","doi-asserted-by":"publisher","first-page":"587","DOI":"10.1016\/j.clinthera.2008.04.002","volume":"30","author":"SG Chrysant","year":"2008","unstructured":"Chrysant SG, Melino M, Karki S, Lee J, Heyrman R . The combination of olmesartan medoxomil and amlodipine besylate in controlling high blood pressure: COACH, a randomized, double-blind, placebo-controlled, 8-week factorial efficacy and safety study. Clin Ther 2008; 30: 587\u2013604.","journal-title":"Clin Ther"},{"key":"BFjhh201646_CR18","doi-asserted-by":"publisher","first-page":"621","DOI":"10.1517\/14740338.2013.816674","volume":"12","author":"G Derosa","year":"2013","unstructured":"Derosa G, Cicero AF, Carbone A, Querci F, Fogari E, D'Angelo A et al. Evaluation of safety and efficacy of a fixed olmesartan\/amlodipine combination therapy compared to single monotherapies. Expert Opin Drug Saf 2013; 12: 621\u2013629.","journal-title":"Expert Opin Drug Saf"},{"key":"BFjhh201646_CR19","first-page":"HC08","volume":"8","author":"J Goyal","year":"2014","unstructured":"Goyal J, Khan ZY, Upadhyaya P, Goyal B, Jain S . Comparative study of high dose mono-therapy of amlodipine or telmisartan, and their low dose combination in mild to moderate hypertension. J Clin Diagn Res 2014; 8: HC08\u2013HC11.","journal-title":"J Clin Diagn Res"},{"key":"BFjhh201646_CR20","doi-asserted-by":"publisher","first-page":"1953","DOI":"10.1016\/j.clinthera.2011.11.007","volume":"33","author":"SM Kang","year":"2011","unstructured":"Kang SM, Youn JC, Chae SC, Park CG, Yang JY, Kim MH et al. Comparative efficacy and safety profile of amlodipine 5\u2009mg\/losartan 50\u2009mg fixed-dose combination and amlodipine 10\u2009mg monotherapy in hypertensive patients who respond poorly to amlodipine 5\u2009mg monotherapy: an 8-week, multicenter, randomized, double-blind phase III noninferiority study. Clin Ther 2011; 33: 1953\u20131963.","journal-title":"Clin Ther"},{"key":"BFjhh201646_CR21","doi-asserted-by":"publisher","first-page":"2581","DOI":"10.1016\/j.clinthera.2015.02.019","volume":"37","author":"H-Y Lee","year":"2015","unstructured":"Lee H-Y, Kim Y-J, Ahn T, Youn H-J, Chull Chae S, Seog Seo H et al. A randomized, multicenter, double-blind, placebo-controlled, 3 \u00d7 3 factorial design, phase II study to evaluate the efficacy and safety of the combination of fimasartan\/amlodipine in patients with essential hypertension. Clin Ther 2015; 37: 2581\u20132596.e2583.","journal-title":"Clin Ther"},{"key":"BFjhh201646_CR22","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1016\/j.kjms.2012.09.005","volume":"29","author":"TH Lin","year":"2013","unstructured":"Lin TH, Tsai CD, Pan JP, Hou CJY, Hsia CH, Tsai JP et al. Efficacy and tolerability between an olmesartan\/amlodipine fixed-dose combination and an amlodipine double dose in mild to moderate hypertension. Kaohsiung J Med Sci 2013; 29: 265\u2013270.","journal-title":"Kaohsiung J Med Sci"},{"key":"BFjhh201646_CR23","doi-asserted-by":"publisher","first-page":"5","DOI":"10.3810\/pgm.2009.03.1972","volume":"121","author":"TW Littlejohn III","year":"2009","unstructured":"Littlejohn TW III, Majul CR, Olvera R, Seeber M, Kobe M, Guthrie R et al. Original research: telmisartan plus amlodipine in patients with moderate or severe hypertension: results from a subgroup analysis of a randomized, placebo-controlled, parallel-group, 4 x 4 factorial study. Postgrad Med 2009; 121: 5\u201314.","journal-title":"Postgrad Med"},{"key":"BFjhh201646_CR24","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1111\/j.1751-7176.2011.00468.x","volume":"13","author":"S Neldam","year":"2011","unstructured":"Neldam S, Lang M, Jones R . Telmisartan and amlodipine single-pill combinations vs amlodipine monotherapy for superior blood pressure lowering and improved tolerability in patients with uncontrolled hypertension: results of the TEAMSTA-5 study. J Clin Hypertens (Greenwich) 2011; 13: 459\u2013466.","journal-title":"J Clin Hypertens (Greenwich)"},{"key":"BFjhh201646_CR25","doi-asserted-by":"publisher","first-page":"35","DOI":"10.2165\/11597170-000000000-00000","volume":"12","author":"CG Park","year":"2012","unstructured":"Park CG, Youn HJ, Chae SC, Yang JY, Kim MH, Hong TJ et al. Evaluation of the dose-response relationship of amlodipine and losartan combination in patients with essential hypertension: an 8-week, randomized, double-blind, factorial, phase II, multicenter study. Am J Cardiovasc Drugs 2012; 12: 35\u201347.","journal-title":"Am J Cardiovasc Drugs"},{"key":"BFjhh201646_CR26","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1111\/j.1742-1241.2008.01977.x","volume":"63","author":"J Schrader","year":"2009","unstructured":"Schrader J, Salvetti A, Calvo C, Akpinar E, Keeling L, Weisskopf M et al. The combination of amlodipine\/valsartan 5\/160\u2009mg produces less peripheral oedema than amlodipine 10\u2009mg in hypertensive patients not adequately controlled with amlodipine 5\u2009mg. Int J Clin Pract 2009; 63: 217\u2013225.","journal-title":"Int J Clin Pract"},{"key":"BFjhh201646_CR27","doi-asserted-by":"publisher","first-page":"294","DOI":"10.1097\/MBP.0000000000000061","volume":"19","author":"JB Park","year":"2014","unstructured":"Park JB, Ha JW, Jung HO, Rhee MY . Randomized trial comparing the effects of a low-dose combination of nifedipine GITS and valsartan versus high-dose monotherapy on central hemodynamics in patients with inadequately controlled hypertension: FOCUS study. Blood Press Monit 2014; 19: 294\u2013301.","journal-title":"Blood Press Monit"},{"key":"BFjhh201646_CR28","doi-asserted-by":"publisher","first-page":"290","DOI":"10.1016\/j.amjmed.2008.09.038","volume":"122","author":"DS Wald","year":"2009","unstructured":"Wald DS, Law M, Morris JK, Bestwick JP, Wald NJ . Combination therapy versus monotherapy in reducing blood pressure: meta-analysis on 11000 participants from 42 trials. Am J Med 2009; 122: 290\u2013300.","journal-title":"Am J Med"},{"key":"BFjhh201646_CR29","doi-asserted-by":"publisher","first-page":"507","DOI":"10.1001\/jama.2013.284427","volume":"311","author":"PA James","year":"2014","unstructured":"James PA, Oparil S, Carter BL, Cushman WC, Dennison-Himmelfarb C, Handler J et al. 2014 evidence-based guideline for the management of high blood pressure in adults: report from the panel members appointed to the Eighth Joint National Committee (JNC 8). JAMA 2014; 311: 507\u2013520.","journal-title":"JAMA"},{"key":"BFjhh201646_CR30","doi-asserted-by":"publisher","first-page":"193","DOI":"10.3109\/08037051.2013.812549","volume":"22","author":"G Mancia","year":"2013","unstructured":"Mancia G, Fagard R, Narkiewicz K, Redon J, Zanchetti A, B\u00f6hm M et al. 2013 ESH\/ESC guidelines for the management of arterial hypertension. Blood Press 2013; 22: 193\u2013278.","journal-title":"Blood Press"},{"key":"BFjhh201646_CR31","doi-asserted-by":"publisher","first-page":"160","DOI":"10.2174\/1871525713666150310111554","volume":"12","author":"FJ Caballero-Gonzalez","year":"2015","unstructured":"Caballero-Gonzalez FJ . Calcium channel blockers in the management of hypertension in the elderly. Cardiovasc Hematol Agents Med Chem 2015; 12: 160\u2013165.","journal-title":"Cardiovasc Hematol Agents Med Chem"},{"key":"BFjhh201646_CR32","doi-asserted-by":"publisher","first-page":"312","DOI":"10.1016\/S0140-6736(10)62003-X","volume":"377","author":"MJ Brown","year":"2011","unstructured":"Brown MJ, McInnes GT, Papst CC, Zhang J, MacDonald TM . Aliskiren and the calcium channel blocker amlodipine combination as an initial treatment strategy for hypertension control (ACCELERATE): a randomised, parallel-group trial. Lancet 2011; 377: 312\u2013320.","journal-title":"Lancet"},{"key":"BFjhh201646_CR33","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1097\/MBP.0b013e32833a23d4","volume":"15","author":"Y Lv","year":"2010","unstructured":"Lv Y, Zou Z, Chen GM, Jia HX, Zhong J, Fang WW . Amlodipine and angiotensin-converting enzyme inhibitor combination versus amlodipine monotherapy in hypertension: a meta-analysis of randomized controlled trials. Blood Press Monit 2010; 15: 195\u2013204.","journal-title":"Blood Press Monit"},{"key":"BFjhh201646_CR34","doi-asserted-by":"publisher","first-page":"1705","DOI":"10.1185\/03007995.2010.487391","volume":"26","author":"Y Ke","year":"2010","unstructured":"Ke Y, Zhu D, Hong H, Zhu J, Wang R, Cardenas P et al. Efficacy and safety of a single-pill combination of amlodipine\/valsartan in Asian hypertensive patients inadequately controlled with amlodipine monotherapy. Curr Med Res Opin 2010; 26: 1705\u20131713.","journal-title":"Curr Med Res Opin"},{"key":"BFjhh201646_CR35","doi-asserted-by":"publisher","first-page":"e1560","DOI":"10.1097\/MD.0000000000001560","volume":"94","author":"R Xu","year":"2015","unstructured":"Xu R, Sun S, Huo Y, Yun L, Huang S, Li G et al. Effects of ACEIs versus ARBs on Proteinuria or albuminuria in primary hypertension: a meta-analysis of randomized trials. Medicine (Baltimore) 2015; 94: e1560.","journal-title":"Medicine (Baltimore)"},{"key":"BFjhh201646_CR36","doi-asserted-by":"publisher","first-page":"341","DOI":"10.4103\/0022-3859.90091","volume":"57","author":"MB Murthy","year":"2011","unstructured":"Murthy MB, Murthy B . Amlodipine-induced petechial rash. J Postgrad Med 2011; 57: 341\u2013342.","journal-title":"J Postgrad Med"},{"key":"BFjhh201646_CR37","first-page":"246","volume":"32","author":"P Tuchinda","year":"2014","unstructured":"Tuchinda P, Kulthanan K, Khankham S, Jongjarearnprasert K, Dhana N . Cutaneous adverse reactions to calcium channel blockers. Asian Pac J Allergy Immunol 2014; 32: 246\u2013250.","journal-title":"Asian Pac J Allergy Immunol"}],"container-title":["Journal of Human Hypertension"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/jhh201646.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/jhh201646","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/jhh201646.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,3,17]],"date-time":"2022-03-17T20:06:12Z","timestamp":1647547572000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/jhh201646"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,8,11]]},"references-count":37,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2017,2]]}},"alternative-id":["BFjhh201646"],"URL":"https:\/\/doi.org\/10.1038\/jhh.2016.46","relation":{},"ISSN":["0950-9240","1476-5527"],"issn-type":[{"value":"0950-9240","type":"print"},{"value":"1476-5527","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,8,11]]},"assertion":[{"value":"2 March 2016","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 May 2016","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 May 2016","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 August 2016","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no conflict of interest.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}